Skip to main content
. 2014 Jun 20;11:112. doi: 10.1186/1742-2094-11-112

Figure 6.

Figure 6

The effect of anti-CKLF1 antibody on myeloperoxidase (MPO) activity. Anti-CKLF1 antibody (0.1, 0.5 or 1 μg) was injected into the right cerebral ventricle immediately after reperfusion. MPO activity was measured in ischemic cortex. Treatment with anti-CKLF1 antibody inhibited the MPO activity in rat ischemic cortex. Each data point shows the mean ± SEM for five rats. ##P < 0.01, compared with sham-operated group; *P < 0.05, compared with vehicle group.